ASX - By Stock
|
AVR |
Re:
Ann: Capital Raise
|
|
barracudaking
|
116 |
30K |
3 |
01/11/23 |
01/11/23 |
ASX - By Stock
|
116
|
30K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anteris to Present at Cantor Healthcare Conference
|
|
barracudaking
|
73 |
26K |
7 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
73
|
26K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
5 |
22/07/23 |
22/07/23 |
ASX - By Stock
|
104
|
43K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Patent for Transcatheter Heart Valve Replacement Technology
|
|
barracudaking
|
25 |
10K |
11 |
15/04/23 |
15/04/23 |
ASX - By Stock
|
25
|
10K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Anteris Channel 9 Interview 2022
|
|
barracudaking
|
98 |
30K |
9 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
98
|
30K
|
9
|
|
ASX - By Stock
|
AVR |
Anteris Channel 9 Interview 2022
|
|
barracudaking
|
98 |
30K |
50 |
15/07/22 |
15/07/22 |
ASX - By Stock
|
98
|
30K
|
50
|
|
ASX - By Stock
|
AVR |
Re:
broker research
|
|
barracudaking
|
9 |
3.6K |
5 |
26/06/22 |
26/06/22 |
ASX - By Stock
|
9
|
3.6K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: DurAVR First In Human Patient 6 Month Study Follow Up
|
|
barracudaking
|
71 |
21K |
8 |
22/06/22 |
22/06/22 |
ASX - By Stock
|
71
|
21K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Application for quotation of securities - AVR
|
|
barracudaking
|
3 |
1.3K |
3 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
3
|
1.3K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Interview with Wayne and Alan Kohler
|
|
barracudaking
|
31 |
14K |
22 |
06/05/22 |
06/05/22 |
ASX - By Stock
|
31
|
14K
|
22
|
|
ASX - By Stock
|
AVR |
Re:
AGM questions to be submitted to the CEO
|
|
barracudaking
|
74 |
23K |
4 |
17/04/22 |
17/04/22 |
ASX - By Stock
|
74
|
23K
|
4
|
|
World Politics
|
|
Re:
Russia Ukraine war
|
|
barracudaking
|
212K |
25M |
4 |
21/03/22 |
21/03/22 |
World Politics
|
212K
|
25M
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Wayne interview with The Market Herald
|
|
barracudaking
|
10 |
4.0K |
10 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
10
|
4.0K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: USD 20M Placement - Perceptive Advisors
|
|
barracudaking
|
21 |
7.8K |
13 |
02/03/22 |
02/03/22 |
ASX - By Stock
|
21
|
7.8K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
Takeover : pool your guesses !
|
|
barracudaking
|
36 |
12K |
3 |
24/02/22 |
24/02/22 |
ASX - By Stock
|
36
|
12K
|
3
|
|
ASX - By Stock
|
AVR |
Anteris Technologies says “no deal” to NASDAQ-lister's merger proposal
|
|
barracudaking
|
0 |
508 |
7 |
17/02/22 |
17/02/22 |
ASX - By Stock
|
0
|
508
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Ceasing to be a substantial holder
|
|
barracudaking
|
39 |
12K |
7 |
16/02/22 |
16/02/22 |
ASX - By Stock
|
39
|
12K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Edwards idea of “lifetime” management.
|
|
barracudaking
|
34 |
11K |
2 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
34
|
11K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Edwards idea of “lifetime” management.
|
|
barracudaking
|
34 |
11K |
8 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
34
|
11K
|
8
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
14 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
104
|
43K
|
14
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
barracudaking
|
141 |
44K |
6 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
141
|
44K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
barracudaking
|
141 |
44K |
19 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
44K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Proposal to Negotiate Non-Binding Letter of Intent - Merger
|
|
barracudaking
|
141 |
44K |
11 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
141
|
44K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
barracudaking
|
28 |
9.0K |
10 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
28
|
9.0K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Interim Results for the First-In-Human Trial
|
|
barracudaking
|
29 |
11K |
6 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
29
|
11K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Successful Interim Results for the First-In-Human Trial
|
|
barracudaking
|
29 |
11K |
5 |
25/01/22 |
25/01/22 |
ASX - By Stock
|
29
|
11K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Adapt - a reminder of the potential value outside of DurAVR.
|
|
barracudaking
|
13 |
4.8K |
13 |
23/01/22 |
23/01/22 |
ASX - By Stock
|
13
|
4.8K
|
13
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
6 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
104
|
43K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
10 |
10/01/22 |
10/01/22 |
ASX - By Stock
|
104
|
43K
|
10
|
|
ASX - By Stock
|
AVR |
Re:
merry xmas and still here
|
|
barracudaking
|
60 |
19K |
5 |
29/12/21 |
29/12/21 |
ASX - By Stock
|
60
|
19K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
AVRO
|
|
barracudaking
|
422 |
104K |
11 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
422
|
104K
|
11
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
3 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
104
|
43K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
7 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
104
|
43K
|
7
|
|
ASX - By Stock
|
AVR |
Re:
Latest interview with Wayne.
|
|
barracudaking
|
7 |
2.0K |
1 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
7
|
2.0K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
5 |
21/09/21 |
21/09/21 |
ASX - By Stock
|
104
|
43K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Peter Switzer interviews CEO Wayne Paterson in The CEO Master Class!
|
|
barracudaking
|
44 |
9.9K |
2 |
18/08/21 |
18/08/21 |
ASX - By Stock
|
44
|
9.9K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
6 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
104
|
43K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
19 |
11/08/21 |
11/08/21 |
ASX - By Stock
|
104
|
43K
|
19
|
|
ASX - By Stock
|
AVR |
Re:
Post AGM proactive interview with Wayne
|
|
barracudaking
|
9 |
2.9K |
0 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
9
|
2.9K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: ADAPT Manufacturing Breakthrough
|
|
barracudaking
|
10 |
4.2K |
3 |
12/07/21 |
12/07/21 |
ASX - By Stock
|
10
|
4.2K
|
3
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Trading Halt
|
|
barracudaking
|
74 |
18K |
12 |
23/05/21 |
23/05/21 |
ASX - By Stock
|
74
|
18K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Pause in Trading
|
|
barracudaking
|
15 |
3.3K |
2 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
15
|
3.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Pause in Trading
|
|
barracudaking
|
15 |
3.3K |
2 |
21/05/21 |
21/05/21 |
ASX - By Stock
|
15
|
3.3K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
2 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
104
|
43K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
AVR charting
|
|
barracudaking
|
104 |
43K |
0 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
104
|
43K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Appendix 2A
|
|
barracudaking
|
24 |
6.4K |
2 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
24
|
6.4K
|
2
|
|
ASX - By Stock
|
AVR |
Q&A With Stock-Pal - Anteris Technologies (ASX:AVR)
|
|
barracudaking
|
2 |
1.1K |
12 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
2
|
1.1K
|
12
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Anti-Calcification Study
|
|
barracudaking
|
107 |
29K |
5 |
29/03/21 |
29/03/21 |
ASX - By Stock
|
107
|
29K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
CEO presentation - one of the best I have seen.
|
|
barracudaking
|
63 |
16K |
4 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
63
|
16K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
New AVR CEO interview
|
|
barracudaking
|
2 |
862 |
8 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
2
|
862
|
8
|
|